載入...
The Clinical Benefits of Dutasteride Treatment for LUTS and BPH
Dutasteride is the first dual inhibitor of both 5α-reductase Types 1 and 2 isoenzymes, with efficacy and safety proven in 3 randomized placebo-controlled trials, each 2 years in duration. The current report demonstrates that longer-term treatment over 48 months with dutasteride results in continuing...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MedReviews, LLC
2004
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1472913/ https://ncbi.nlm.nih.gov/pubmed/16985921 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|